Stay updated on Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.

Latest updates to the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page
- Check3 days agoChange DetectedThe page now includes a recruitment status update 'No longer looking for participants' and adds new help/navigation sections such as How to Read a Study Record, Common Questions, and How to Join a Study. The Interventions heading has been updated (Intervention/Treatment added, Intervention / Treatment removed) and the revision tag changed from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check9 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5, indicating a minor update to the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page revision label was updated to v3.5.4, indicating a new internal release of the page rendering.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page footer software revision was updated from **Revision: v3.5.0** to **Revision: v3.5.3**.SummaryDifference0.0%

- Check74 days agoChange DetectedLocations updated: added Hôpital de l'Archet, Charité - Universitätsmedizin Berlin, and Queen Elizabeth Hospital; removed HOP l'Archet, Charité Universitätsmedizin Berlin KöR, and Queen Elizabeth Hospital-Kota Kinabalu-40735. An EU CTIS number (2023-509216-28-00) was added along with a data-sharing link.SummaryDifference0.3%

- Check88 days agoChange DetectedRevision: v3.5.0 is now displayed, replacing Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.